The above-mentioned authors investigated the number of macrophages in tumor tissue, while we were able to show that the percentages of CD68+, CD68+CD163+, and CD68+CD206+ cells in PBMCs was significantly higher in advanced UICC stages than in limited stages and HCs (p < 0.05, ANOVA). The gene discussed is CD163; the disease is neoplasm.